Shining Loo

Dr. Shining Loo joined the Academy of Pharmacy at Xi’an Jiaotong-Liverpool University as an Assistant Professor in 2023. Dr. Loo received First-Class Honors in a Double Bachelor’s Degree in Biomedical Science and Traditional Chinese Medicine (TCM) from the Nanyang Technological University (NTU), School of Biological Sciences (SBS), Singapore, and the Beijing University of Chinese Medicine, Beijing, China. She is also a licensed practicing TCM physician in Singapore. She was awarded the prestigious Nanyang President’s Graduate Scholarship and received her Ph.D. in Biological Sciences at NTU, SBS, Singapore, under the supervision of Professor James P. Tam (2013-2018). Upon graduation, Dr. Loo was appointed as a Research Fellow and continued her postdoctoral research work with Professor Tam’s group (2018-2023).Dr. Loo’s research interests center around peptide drug discovery and their translational applications for precision medicine, theranostics, drug delivery, material, and food technologies. Dr. Loo has published over 15 peer-reviewed publications in well-recognized journals like the Journal of American Chemical Society, Angewandte Chemie International Edition, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Frontiers in Pharmacology, and Frontiers in Plant Sciences. She also holds 2 US and China national phase patent applications. In 2021, Dr. Loo won the Mistletoe Research Fellowship, the title of Mistletoe Research Fellow, and an Unfettered Research Grant from the Momental Foundation. She was also awarded the Merck Life Science Publication Award (First Prize) for her research contributions in the field of biology and biochemistry.

Led by Dr. Shining Loo (Wisdom Lake Academy of Pharmacy) and Dr. Antony Kam (Department of Biological Sciences) at Xi'an JiaoTong Liverpool University), XPad (XJTLU Peptide and Drug) is a collaborative research group at the forefront of peptide-based technologies. We leverage our expertise in molecular pharmacology, synthetic biology, and chemical biology to develop innovative solutions for:

• Therapeutics: Designing next-generation drugs with targeted precision to combat various diseases.

• Diagnostics: Creating highly accurate and personalized medical tests for early disease detection and personalized treatment.

• Biomaterials: Engineering advanced materials for tissue regeneration and repair, promoting healing and improving lives.

• Drug Delivery Systems: Revolutionizing how therapeutics are delivered safely and effectively, maximizing their impact.

She welcomes interested academic and industrial collaborations as well as students to join her group.Interested parties can contact via e-mail: Shining.loo@xjtlu.edu.cn

Read more about our XPad XJTLU Peptide and Drug research group!